News & Features

Our quarterly publication, Virginia Economic Review, provides an insider look at Virginia’s economy, its diverse array of world-class companies, its amazing talent, and its stunning natural beauty, as well as insights from national thought leaders.

VER Issue

Second Quarter 2026
First Quarter 2026
Fourth Quarter 2025
Third Quarter 2025
Second Quarter 2025
First Quarter 2025
Fourth Quarter 2024
Third Quarter 2024
Second Quarter 2024
First Quarter 2024
Fourth Quarter 2023
Third Quarter 2023
Second Quarter 2023
First Quarter 2023
Fourth Quarter 2022
Third Quarter 2022
Second Quarter 2022
First Quarter 2022
Fourth Quarter 2021
Third Quarter 2021
Second Quarter 2021
First Quarter 2021
Fourth Quarter 2020
Third Quarter 2020
Second Quarter 2020
First Quarter 2020
Fourth Quarter 2019
Third Quarter 2019
Second Quarter 2019
First Quarter 2019

Topics

Business Climate
Foreign Direct Investment
Infrastructure & Distribution
Innovation
International Trade
Living in Virginia
Made in Virginia
Rural
Talent and Workforce Development

Industry

Advanced Materials Manufacturing
Aerospace & Defense
Business & Financial Services
Cloud & AI Infrastructure
Energy Supply Chain
Food & Beverage Manufacturing
Life Sciences
Tech & Cyber
Supply Chain Management
Automotive & Battery Manufacturing
Quantum Computing
Semiconductors
Building Materials & Wood Products
Industrial Machine Manufacturing

Region

Central Virginia
Eastern Shore
Greater Fredericksburg
Greater Richmond
Hampton Roads
I81-I77 Crossroads
I95-I85 Intersection
Lynchburg Region
Middle Peninsula
New River Valley
Northern Neck
Northern Shenandoah Valley
Northern Virginia
Roanoke Region
Shenandoah Valley
South Central Virginia
Southern Virginia
Southwest Virginia

First Quarter 2026XTalent and Workforce DevelopmentXCentral VirginiaX

Caption

04.09.2026

Talent and Workforce Development

Life Sciences

Inside Virginia’s Rise to Biopharma Prominence

As the world continues to struggle with drug supply chains and critical shortages, clusters of activity have emerged to move the needle of medication affordability and accessibility.